The Australia-China Centre for Personal Heath Technologies is a collaborative Centre established to develop a personal device that can detect health conditions from bodily fluids (e.g. sweat, saliva, blood or urine) using a technology called aggregation induced emission luminogens (AIEgens).
The results from the tests will display on a computer or smartphone and link to e-health services for further analysis by medical professionals.
To date, the Centre’s work has been focussed on a test to detect proteins in urine to diagnose chronic kidney disease (CKD), however we are also looking for other health conditions the device could diagnose.
To ensure the research we are undertaking meets real-world demand, fourteen experts from a range of medical and scientific backgrounds were consulted to provide feedback on the Centre’s research and future direction.
The feedback we received on CKD suggested that the device being developed would be useful for screening or
monitoring in rural or remote health clinics. They also provided a list of biomarkers (the ‘marker’ in bodily fluids that indicates specific condition) both with and without associated AIEgens that were potential tests that could be developed in the future. These future test ideas will allow the Centre to start focusing on unmet needs in the community and healthcare settings to aid in the diagnosis and tracking of major health conditions.
The Australia-China Centre for Personal Heath Technologies was established in June 2019 with funding from the Department of Industry, Science, Energy and Resources. The Centre is an international partnership led by Flinders University in Australia and Nankai University in China. Other partners include La Trobe University and Motherson Innovations (Australia) and South China University of Technology, Shandong Academy of Sciences and AIEgen Biotech (China).